AMPK also has a major role in pathological conditions (e.g. metabolic syndrome, cancer, Alzheimer's disease) and therapeutic activation of AMPK is believed to have beneficial advantages for several disease processes. Here, PRKAA1 is linked to early-onset autosomal dominant Alzheimer disease.